ZELDA Trademark

Trademark Overview


On Monday, July 29, 2019, a trademark application was filed for ZELDA with the United States Patent and Trademark Office. The USPTO has given the ZELDA trademark a serial number of 79268101. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, March 24, 2021. This trademark is owned by ZELIRA THERAPEUTICS LIMITED. The ZELDA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medical cannabis and derivatives thereof; preparations for medical purposes derived from cannabis; therapeutic agents (medical); therapeutic creams (medical); therapeutic drugs (medical); natural healthcare preparations (medicaments); natural oils (medicinal); natural pharmaceutical products; pharmaceutical products derived from natural sources; pharmaceutical preparations; pharmaceutical preparations for human use; medical preparations; pharmaceutical preparations for health care; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for topical use; pharmaceutical preparations and substances for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cog...

Clinical trials; project management and planning of clinical trials; conducting clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; research and development of medicinal marijuana and cannabis products; medical research; medical research (scientific research for medical purposes); scientific research; research relating to science; provision of medical research services
zelda

General Information


Serial Number79268101
Word MarkZELDA
Filing DateMonday, July 29, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, March 24, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical cannabis and derivatives thereof; preparations for medical purposes derived from cannabis; therapeutic agents (medical); therapeutic creams (medical); therapeutic drugs (medical); natural healthcare preparations (medicaments); natural oils (medicinal); natural pharmaceutical products; pharmaceutical products derived from natural sources; pharmaceutical preparations; pharmaceutical preparations for human use; medical preparations; pharmaceutical preparations for health care; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for topical use; pharmaceutical preparations and substances for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, alzheimer's, depression, autism and post-traumatic stress disorder; pain killers (pharmaceuticals); pharmaceutical preparations in the form of foams, gels, emulsions, elixirs, lotions, ointments, tinctures, creams, liquids, oils, lozenges, tablets, capsules, sprays and skin patches; analgesic preparations; antibacterial preparations; medical products; medicinal plants and herbs; medicinal oils; herbal preparations for medical purposes; plant extracts for medical use; plant extracts for pharmaceutical use; preparations for medical purposes
Goods and ServicesClinical trials; project management and planning of clinical trials; conducting clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; research and development of medicinal marijuana and cannabis products; medical research; medical research (scientific research for medical purposes); scientific research; research relating to science; provision of medical research services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZELIRA THERAPEUTICS LIMITED
Party Type10 - Original Applicant
Legal Entity Type83 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Sunday, April 10, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 24, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 24, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, March 24, 2021ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, March 24, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, March 20, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, January 2, 2021NEW REPRESENTATIVE AT IB RECEIVED
Saturday, October 3, 2020REFUSAL PROCESSED BY IB
Monday, September 7, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 3, 2020REFUSAL PROCESSED BY MPU
Wednesday, August 5, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 4, 2020NON-FINAL ACTION WRITTEN
Tuesday, August 4, 2020ASSIGNED TO EXAMINER
Friday, May 22, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, October 20, 2019ASSIGNED TO EXAMINER
Tuesday, October 8, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, October 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 26, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB